What is the recommended treatment for a patient with bacterial sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Sinusitis

Amoxicillin-clavulanate is the preferred first-line antibiotic for acute bacterial sinusitis in both adults and children, with empiric therapy initiated as soon as the clinical diagnosis is established. 1

Confirming the Diagnosis Before Starting Antibiotics

Before prescribing antibiotics, confirm bacterial sinusitis using one of three clinical patterns 1:

  • Persistent symptoms ≥10 days without improvement (nasal discharge, congestion, facial pain/pressure) 1
  • Severe symptoms for ≥3 consecutive days (fever ≥39°C with purulent nasal discharge) 1
  • "Double sickening" - worsening after initial improvement from a viral upper respiratory infection 1

Most acute rhinosinusitis (98-99.5%) is viral and resolves spontaneously within 7-10 days without antibiotics 2. Do not prescribe antibiotics for symptoms lasting <10 days unless severe symptoms are present 2.

First-Line Antibiotic Treatment

Adults

Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-7 days is the preferred first-line treatment 1, 2. The IDSA guideline explicitly recommends amoxicillin-clavulanate over amoxicillin alone due to coverage against β-lactamase-producing Haemophilus influenzae and Moraxella catarrhalis 1.

High-dose amoxicillin-clavulanate (2 g/250 mg twice daily) should be used for patients with 1, 2:

  • Recent antibiotic use within the past 4-6 weeks
  • Age >65 years
  • Moderate-to-severe symptoms
  • Comorbid conditions or immunocompromised state
  • Geographic areas with high rates of penicillin-resistant Streptococcus pneumoniae

Children

High-dose amoxicillin-clavulanate (90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses) is recommended as first-line therapy 1, 2. Children require the longer treatment duration of 10-14 days 1.

Standard-dose amoxicillin (45 mg/kg/day in 2 divided doses) may be used for uncomplicated cases without risk factors 2.

Treatment Duration

  • Adults: 5-7 days for uncomplicated cases 1
  • Children: 10-14 days 1
  • Alternative guideline: Treat until symptom-free for 7 days (typically 10-14 days total) 2

When to Reassess and Switch Antibiotics

Reassess at 3-5 days (adults) or 72 hours (children) 1, 2:

If symptoms worsen or fail to improve, switch to second-line therapy 1:

  • Respiratory fluoroquinolones (levofloxacin 500 mg once daily or moxifloxacin 400 mg once daily for 10 days) provide 90-92% predicted clinical efficacy 1, 2
  • High-dose amoxicillin-clavulanate (if not already used) 2
  • Third-generation cephalosporins (cefpodoxime, cefdinir) for superior H. influenzae coverage 2

Penicillin-Allergic Patients

Non-Type I Allergy (Rash, Mild Reactions)

Second- or third-generation cephalosporins are safe to use 2, 3:

  • Cefuroxime-axetil 2, 3
  • Cefpodoxime-proxetil 2, 3
  • Cefdinir 2, 3

Recent evidence shows the risk of serious allergic reactions to second- and third-generation cephalosporins in penicillin-allergic patients is negligible 2, 3.

Type I Allergy (Anaphylaxis)

Respiratory fluoroquinolones are the first-line choice 2, 3:

  • Levofloxacin 500 mg once daily for 10-14 days 2, 3
  • Moxifloxacin 400 mg once daily for 10 days 2, 3

Doxycycline 100 mg once daily for 10 days is an acceptable alternative but has a predicted bacteriologic failure rate of 20-25% and limited activity against H. influenzae 2.

What NOT to Use

  • Azithromycin and other macrolides should not be used as first-line therapy due to resistance rates exceeding 20-25% for both S. pneumoniae and H. influenzae 1, 2
  • Trimethoprim-sulfamethoxazole has resistance rates of 50% for S. pneumoniae and 27% for H. influenzae 2
  • First-generation cephalosporins (cephalexin, cefadroxil) have inadequate coverage against H. influenzae 2
  • Routine coverage for MRSA is not recommended during initial empiric therapy 1

Essential Adjunctive Therapies

These improve outcomes regardless of antibiotic choice 1, 2:

  • Intranasal corticosteroids (mometasone, fluticasone, or budesonide twice daily) reduce mucosal inflammation 1, 2
  • Saline nasal irrigation (physiologic or hypertonic) provides symptomatic relief 1, 2
  • Analgesics (acetaminophen, NSAIDs) for pain and fever 2
  • Adequate hydration, warm facial packs, sleeping with head elevated 2

Do NOT use topical or oral decongestants/antihistamines as adjunctive treatment - they are not recommended 1.

When to Refer to a Specialist

Refer to otolaryngology when 1, 2:

  • Symptoms refractory to two courses of appropriate antibiotics
  • Recurrent sinusitis (≥3 episodes per year)
  • Suspected complications (orbital cellulitis, meningitis, brain abscess)
  • Immunocompromised patients who continue to deteriorate despite extended antimicrobial therapy
  • Need for sinus aspiration/culture

Critical Pitfalls to Avoid

  • Do not prescribe antibiotics for viral rhinosinusitis lasting <10 days unless severe symptoms are present 2
  • Do not use fluoroquinolones as routine first-line therapy in patients without documented β-lactam allergies - reserve them to prevent resistance 2
  • Do not continue ineffective therapy beyond 3-5 days (adults) or 72 hours (children) without reassessment 1, 2
  • Complete the full antibiotic course even after symptoms improve to prevent relapse 2, 4
  • Take amoxicillin-clavulanate with food to reduce gastrointestinal upset 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Antibiotic Options for Sinusitis in Patients Allergic to Penicillin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.